Freytes C - Search Results

1

Durable complete remission in a patient with refractory mediastinal non-seminomatous germ cell tumor after tandem high-dose chemotherapy and autologous bone marrow transplantation.

Adkins D, Encarnacion C, Salzman D, Boldt D, Freytes C, Von Hoff DD, LeMaistre CF. Adkins D, et al. Among authors: freytes c. Bone Marrow Transplant. 1993 Nov;12(5):541-6. Bone Marrow Transplant. 1993. PMID: 7507767

2

Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.

Adkins DR, Salzman D, Boldt D, Kuhn J, Irvin R, Roodman GD, Lyons R, Smith L, Freytes CO, LeMaistre CF. Adkins DR, et al. Among authors: freytes co. J Clin Oncol. 1994 Sep;12(9):1890-901. doi: 10.1200/JCO.1994.12.9.1890. J Clin Oncol. 1994. PMID: 7916039 Clinical Trial.

3

A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.

Adkins DR, Irvin R, Kuhn J, Boldt DH, Roodman GD, Salzman D, Freytes C, Von Hoff DD, LeMaistre CF. Adkins DR, et al. Among authors: freytes c. Invest New Drugs. 1993 May-Aug;11(2-3):169-79. doi: 10.1007/BF00874151. Invest New Drugs. 1993. PMID: 8262729 Clinical Trial.

4

Representation of Hispanics in the National Marrow Donor Program.

Freytes CO, Beatty PG. Freytes CO, et al. Bone Marrow Transplant. 1996 Mar;17(3):323-7. Bone Marrow Transplant. 1996. PMID: 8704681

5

Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review.

Salzman D, Adkins DR, Craig F, Freytes C, LeMaistre CF. Salzman D, et al. Among authors: freytes c. Bone Marrow Transplant. 1996 Oct;18(4):755-60. Bone Marrow Transplant. 1996. PMID: 8899191 Review.

6

Cokeromyces recurvatus infection in a bone marrow transplant recipient.

Tsai TW, Hammond LA, Rinaldi M, Martin K, Tio F, Maples J, Freytes CO, Roodman GD. Tsai TW, et al. Among authors: freytes co. Bone Marrow Transplant. 1997 Feb;19(3):301-2. doi: 10.1038/sj.bmt.1700647. Bone Marrow Transplant. 1997. PMID: 9028564

7

Allogenic bone marrow transplantation for leukemias and aplastic anemia.

Tsai TW, Freytes CO. Tsai TW, et al. Among authors: freytes co. Adv Intern Med. 1997;42:423-51. Adv Intern Med. 1997. PMID: 9048126 Review.

8

Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation.

Tsai T, Goodman S, Saez R, Schiller G, Adkins D, Callander N, Wolff S, Freytes CO. Tsai T, et al. Among authors: freytes co. Bone Marrow Transplant. 1997 Nov;20(10):859-63. doi: 10.1038/sj.bmt.1700989. Bone Marrow Transplant. 1997. PMID: 9404927

9

Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2.

LeMaistre CF, Saleh MN, Kuzel TM, Foss F, Platanias LC, Schwartz G, Ratain M, Rook A, Freytes CO, Craig F, Reuben J, Nichols JC. LeMaistre CF, et al. Among authors: freytes co. Blood. 1998 Jan 15;91(2):399-405. Blood. 1998. PMID: 9427692 Free article. Clinical Trial.

10

Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.

Saleh MN, LeMaistre CF, Kuzel TM, Foss F, Platanias LC, Schwartz G, Ratain M, Rook A, Freytes CO, Craig F, Reuben J, Sams MW, Nichols JC. Saleh MN, et al. Among authors: freytes co. J Am Acad Dermatol. 1998 Jul;39(1):63-73. doi: 10.1016/s0190-9622(98)70403-7. J Am Acad Dermatol. 1998. PMID: 9674399 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters